Access Natriuretic Peptide Assay(s) Pivotal - Emergency Department Subject Enrollment and Specimen Collection

NCT04169815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2370

Last updated 2023-02-14

No results posted yet for this study

Summary

The purpose of the pivotal study is to collect blood specimens and clinical data from patients suspected of having Heart Failure (HF), which will be tested at a future date on Natriuretic Peptide assay(s) to validate diagnostic cutoffs and assess HF severity.

Conditions

Interventions

DIAGNOSTIC_TEST

Access Immunodiagnostic Products

Access Natriuretic Peptide Assay

Sponsors & Collaborators

  • Beckman Coulter, Inc.

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-20
Primary Completion
2022-05-31
Completion
2022-09-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04169815 on ClinicalTrials.gov